What this is
Single filing record
This page shows the rows from one Form 4 filing as reported to the SEC.
Big buy
Patrick J Heron: large open-market buy of MBX
$12M open-market purchase by Patrick J Heron, Director at Mbx Biosciences,Inc., filed September 30, 2025. Learn more
Feed status Last SEC check:Loading Last Filing: Loading
View MBX
Access Free feed
Quick read What does this view show?
Why it matters
Read the SEC filing
The original SEC document is the source record. Always verify before drawing conclusions.
How to read it
Role, size, timing
Insider activity carries more weight from senior officers, large dollar values, and clustered timing.
Stacked feeds
Key insider views at a glance
Insider purchase
Patrick J Heron bought $12M of MBX
Patrick J Heron, a Director, reported a $12M open-market purchase equal to 0.85% of MBX's market cap.
Patrick J Heron (Director) bought 666,666 shares of MBX, Mbx Biosciences,Inc., Healthcare ($1.41B market cap), at $18.00 per share on September 26, 2025 for a total of $12M (0.85% of the market cap).
- % of market cap
- 0.85%
- Purchase value
- $12M
- Shares purchased
- 666,666
- Price per share
- $18.00 per share
- Trade date
- September 26, 2025
- Filed
- September 30, 2025
- Filing delay
- 4 days
Permalink https://bluecollarpicks.com/insider-trading/MBX/buy/67947
Market context
MBX market snapshot
Last enriched May 6, 2026 at 8:03 AM EDT.
Filings
Recent insider trades
Status Loading
Latest visible filing loading.
Public Form 4 filings, normalized for cleaner scanning.
| Ticker | Type & Role | Value | Filed |
|---|---|---|---|
Grant Director | $0 | ||
Big Buy CEO | $525.7K | ||
Exercise and Hold CEO | $460.3K | ||
Exercise and Hold CEO | Not reported | ||
Grant Officer | $0 | ||
Free weekly recapGet the easiest version of the insider feed in your inbox. | |||
Grant Officer | $0 | ||
Grant CFO | $0 | ||
Grant CFO | $0 | ||
Grant CEO | $0 | ||
Grant CEO | $0 | ||
Grant Director | $0 | ||
Cluster Buy CEO | $272.8K | ||
Cluster Buy Director | $265K | ||
| This filing | Big Buy Director | $12M | |
Buy Director | $45.3K | ||
Free weekly recapGet the easiest version of the insider feed in your inbox. | |||
Cluster Buy Director | $1M | ||
Cluster Buy Director | $531.9K | ||
Cluster Buy Director | $531.9K | ||
Cluster Buy Director | $1M | ||
Cluster Buy Director | $1M | ||
Cluster Buy Director | $1M | ||
Cluster Buy Director | $531.9K | ||
Cluster Buy Director | $531.9K | ||
Cluster Buy Director | $291K | ||
Cluster Buy Director | $177.8K | ||
Free weekly recapGet the easiest version of the insider feed in your inbox. | |||
Cluster Buy Director | $291K | ||
Cluster Buy Director | $291K | ||
Cluster Buy Director | $291K | ||
Cluster Buy Director | $177.8K | ||
Cluster Buy Director | $177.8K | ||
Cluster Buy Director | $177.8K | ||
Big Buy CEO | $534.5K | ||
Grant Director
$525.7K
Big Buy CEO
$460.3K
Exercise and Hold CEO
Not reported
Exercise and Hold CEO
Grant Officer
Grant Officer
Grant CFO
Grant CFO
Grant CEO
Grant CEO
Grant Director
$272.8K
Cluster Buy CEO
$265K
Cluster Buy Director
$12M
Big Buy Director
$45.3K
Buy Director
$1M
Cluster Buy Director
$531.9K
Cluster Buy Director
$531.9K
Cluster Buy Director
Cluster Buy Director
Cluster Buy Director
Cluster Buy Director
$531.9K
Cluster Buy Director
$531.9K
Cluster Buy Director
$291K
Cluster Buy Director
$177.8K
Cluster Buy Director
Cluster Buy Director
$291K
Cluster Buy Director
$291K
Cluster Buy Director
$177.8K
Cluster Buy Director
$177.8K
Cluster Buy Director
$177.8K
Cluster Buy Director
$534.5K
Big Buy CEO
Cluster detail
Cluster members
Ticker context
Ticker summary
Recent insider activity for this company.
Insider detail
Insider activity
Recent transactions grouped by reporting owner.
Filters
Filters
Weekly recap
Get the easier version in your inbox.
Start with the free weekly recap. Upgrade later if you want the paid daily brief.
Free weekly recap. No login required. Unsubscribe any time.
Method
Public data, presented plainly
Named views
Ready-made views give you a clear starting point before you touch filters.
Cluster logic
Cluster buys mean multiple insiders buying the same ticker inside a short window.
Normalized rows
Rows preserve filing date, trade date, role, value, and source links where available.
All data remains available
Filtered rows are not hidden. Grants, exercises, tax withholding, gifts, and conversions stay available in All Form 4 Filings, ticker history, and specialized views.
Paid research tools
CSV exports are becoming a paid feature.
Join the waitlist for founding-member access to CSV exports, saved screens, and premium download tools when they open.